Compare RXO & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RXO | CNC |
|---|---|---|
| Founded | 2022 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 33.5B |
| IPO Year | 2022 | 2001 |
| Metric | RXO | CNC |
|---|---|---|
| Price | $20.01 | $67.37 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 16 |
| Target Price | $16.33 | ★ $46.75 |
| AVG Volume (30 Days) | 1.3M | ★ 2.7M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.81 | N/A |
| EPS | N/A | ★ 5.30 |
| Revenue | $5,742,000,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | $0.49 | $8.31 |
| Revenue Next Year | $6.90 | $1.05 |
| P/E Ratio | ★ N/A | $12.87 |
| Revenue Growth | ★ 26.20 | 19.44 |
| 52 Week Low | $10.43 | $31.63 |
| 52 Week High | $29.90 | $69.36 |
| Indicator | RXO | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 33.17 | 51.29 |
| Support Level | $17.20 | $62.36 |
| Resistance Level | $20.19 | $68.48 |
| Average True Range (ATR) | 1.04 | 2.14 |
| MACD | -0.06 | 0.05 |
| Stochastic Oscillator | 5.46 | 57.80 |
RXO Inc is a brokered transportation platform defined by technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.